2020 Biotech Startups
Order by: Company Name - Location
 Retinagenix Therapeutics |
- | 9-cis-retinyl acetate |
| Chimeric Therapeutics |
Australia - Carlton | CAR-T Therapies |
| Bionovica |
Australia - Sydney | Out-license/tech-transfer and consulting |
| Rakovina Therapeutics |
BC - Vancouver | Small Molecules |
| ExeVir |
Belgium - Ghent | Llama-derived antibodies |
| Lisa Cryobanking |
CA - Carlsbad | Cryobanking |
| Revelation Biosciences |
CA - Menlo Park | Immunologic Therapeutics & Diagnostics |
| atHeart Medical |
CA - Mountain View | Device for closure of atrial septal defects |
| R3 Vascular |
CA - Mountain View | Fully bioresorbable vascular scaffolds |
| Adari Cell Science |
CA - Oakland | Cell-based Assays |
| 180 Life Sciences |
CA - Palo Alto | Cannabinoids |
| Sestina Bio |
CA - Pleasanton | Automated Synthetic Biology |
| Abintus Bio |
CA - San Diego | Gene Therapy |
| Aegis Life |
CA - San Diego | Vaccines & Therapeutics |
| Enosi Life Sciences |
CA - San Diego | Anti-TNF therapeutics for inflammatory autoimmune diseases and cancer |
| IconOVir Bio |
CA - San Diego | Oncolytic Virus Therapy |
| Longboard Pharmaceuticals |
CA - San Diego | Novel central nervous system-targeted assets |
| RayzeBio |
CA - San Diego | Radiopharmaceuticals Therapy for Cancer |
| Replicate Bioscience |
CA - San Diego | Preventing oncology drug resistance |
| Resilience |
CA - San Diego | Biomanufacturing |
| Tentarix Biotherapeutics |
CA - San Diego | Logic-Gated Multivalent Molecules |
| AmbAgon Therapeutics |
CA - San Francisco | Small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins |
| Weatherwax |
CA - San Francisco | Next-gen bifunctional small molecule drug discovery |
| Vincerx Pharma |
CA - Santa Clara | Small Molecules |
| Nooma Bio |
CA - Santa Cruz | Nanopores to control and map genomic and epigenetic features on single molecules of high molecular weight DNA |
| Altay Therapeutics |
CA - South SF | Small molecules for liver disease and cancer |
| Attralus |
CA - South SF | Amyloidosis Treatments |
| Graphite Bio |
CA - South SF | Next Generation Gene-Editing |
| Trishula Therapeutics |
CA - South SF | Cancer Immunotherapy |
| Allorion Therapeutics |
China - Guangzhou | Small molecule drugs against cancer and autoimmune diseases |
| Overland Pharmaceuticals |
China - Shanghai | Novel Therapeutics |
| SciNeuro Pharmaceuticals |
China - Shanghai | Neuro Treatments |
| Foresight Diagnostics |
CO - Louisville | Cancer Diagnostics |
| Captivate Bio |
CT - Berlin | Cell Culture Products |
| EvolveImmune Therapeutics |
CT - Branford | Novel Immunotherapy Targets |
| AtlasXomics |
CT - New Haven | Spatial imaging technique for genomics |
| Proteowise |
CT - New Haven | High-throughput Proteomics |
| Bionovica |
FL - Jacksonville | Out-license/tech-transfer and consulting |
| Enveric Biosciences |
FL - Naples | Cannabinoids |
| InnoSkel |
France - Valbonne | Therapies for Rare Skeletal Diseases |
| ActiTrexx |
Germany - Mainz | Cell Therapies That Avoid Transplant Rejection |
| Resolve Biosciences |
Germany - Monheim am Rhein | Molecular Cartography |
| FBB Biomed |
IA - Coralville | Liquid Biopsy |
| Evozyne |
IL - Chicago | Protein Design Platform |
| Bicara Therapeutics |
India - Bangalore | Dual-Action Biologics, Antibodies |
| Genuity Science |
Ireland - Dublin | Genomic Data Platform |
| GentiBio |
Israel - Qiryat Shmona | Engineered regulatory T cells |
| Genespire |
Italy - Milano | Gene Therapy |
| Acenxion Biosystems |
KS - Kansas City | Direct Detection of Microbes |
| Invictech |
KY - Louisville | Microfluidics |
| Tectonic Therapeutic |
MA - Allston | GPCR Targeting Drugs |
| Delix Therapeutics |
MA - Boston | Psychoplastogens |
| Genuity Science |
MA - Boston | Genomic Data Platform |
| Kinaset Therapeutics |
MA - Boston | Novel, inhaled small-molecule pan-JAK inhibitor |
| Resilience |
MA - Boston | Biomanufacturing |
| Scorpion Therapeutics |
MA - Boston | Small Molecules |
| SalioGen Therapeutics |
MA - Burlington | Gene Therapy Platform Technology |
| Alphageneron Pharmaceuticals |
MA - Cambridge | Natural Killer Therapy |
| Bicara Therapeutics |
MA - Cambridge | Dual-Action Biologics, Antibodies |
| Catamaran Bio |
MA - Cambridge | CAR-Natural Killer Cell Therapies |
| Exo Therapeutics |
MA - Cambridge | Small Molecule Drug Discovery |
| Faze Medicines |
MA - Cambridge | Treatments for Disease-Causing Condensates |
| Moma Therapeutics |
MA - Cambridge | Enzymes - Molecular Machines |
| Myeloid Therapeutics |
MA - Cambridge | Cell Therapy for Cancer |
| Nereid Therapeutics |
MA - Cambridge | Small molecules that can modulate protein interactions found in disease states |
| Tessera Therapeutics |
MA - Cambridge | Gene Writing |
| Torus Biosystems |
MA - Cambridge | Diagnostics |
| Transition Bio |
MA - Cambridge | Condensate technology, liquid-liquid phase separation |
| Vigil Neurosciences |
MA - Cambridge | Microglia-based Therapeutics for Neurodegenerative Diseases |
| Walden Biosciences |
MA - Cambridge | Podocyte-targeting Kidney Disease Treatments |
| Allorion Therapeutics |
MA - Natick | Small molecule drugs against cancer and autoimmune diseases |
| GelMedix |
MA - Newton | Biomaterials for improved drug delivery |
| Adagio Therapeutics |
MA - Waltham | Antibodies |
| Resilience |
MA - Waltham | Biomanufacturing |
| ValenzaBio |
MD - Bethesda | Monoclonal Antibodies |
| Atsena Therapeutics |
NC - Durham | Gene Therapy |
| VectorY |
Netherlands - Amsterdam | Vectorized Antibodies |
| AmbAgon Therapeutics |
Netherlands - Eindhoven | Small molecule cancer drugs that stabilize the direct interaction of oncogenic proteins with the 14-3-3 class of adaptor proteins |
| Infinity BiologiX |
NJ - Piscataway | Biologics Services & Research |
| Tevogen Bio |
NJ - ZZ | T Cell Therapy for Covid |
| Fixx Pharmaceuticals |
NV - Las Vegas | Developing a cure for Hemophilia through the use of CRISPR gene editing |
| Graviton Bioscience |
NY - New York | Small Molecule |
| Volastra Therapeutics |
NY - New York | Therapies for the treatment of metastatic cancers |
| Clarametyx Biosciences |
OH - Columbus | Antibodies |
| Forge Biologics |
OH - Columbus | Biologics |
| Resilience |
ON - Mississauga | Biomanufacturing |
| POINT Biopharma |
ON - Toronto | Radioligand Therapies |
| Larimar Therapeutics |
PA - Bala Cynwyd | Small Molecules |
| Seneca Therapeutics |
PA - Blue Bell | Oncolytic immunotherapeutic |
| Mineralys Therapeutics |
PA - Radnor | Small Molecules |
| SP Lab Services |
PA - Southampton | Contract Services |
| SDiversity |
Portugal - Porto | Experience in animal immunizations and other in vivo preclinical studies for the industry and scientific community. |
| Neuroglee Therapeutics |
Singapore - Singapore | Digital Therapeutic Platform |
| Accure Therapeutics |
Spain - Barcelona | Neuro Treatments |
| Avrion Therapeutics |
Switzerland - Allschwil | Gene Therapies for Neurodegenerative Diseases |
| atHeart Medical |
Switzerland - Baar | Device for closure of atrial septal defects |
| Chord Therapeutics |
Switzerland - Geneva | Oral disease-modifying therapies |
| Taysha Gene Therapies |
TX - Dallas | Adeno-associated virus gene therapies |
| Coya Therapeutics |
TX - Houston | Ex-Vivo Treg Modification for ALS |
| SynOx Therapeutics |
UK - | Therapeutic Antibody |
| Dunad Therapeutics |
UK - Cambridge | Pioneering Tunable Small-Molecule Degradation Platform |
| Macomics |
UK - Edinburgh | Immunotherapies |
| Senisca |
UK - Exeter | Antisense Oligonucleotides for Senescence |
| T-Cypher Bio |
UK - Oxford | TCR-based Therapeutics |
| Modulus Oncology |
UK - Sheffield | G protein-coupled receptor antagonists |
| Noeledge |
WA - Monroe | Consultant offering marketing services to various businesses in the healthcare sector |